Swiss technology group OC Oerlikon says it will cut 800 jobs worldwide in the face of an economic slowdown caused by the coronavirus pandemic. Orders in the first three months of 2020 fell nearly 30% compared to the same period last year, with revenues sagging 15%.
This content was published on
1 minute
swissinfo.ch/mga
Русский
ru
Швейцарский холдинг OC Oerlikon сократит 800 рабочих мест
The company’s surface solutions divisions, which provides coatings for a variety of sectors, has been particularly badly hit by the downturn in the automobile and aircraft industries. Headcount in the business segment will be reduced 10% – or by 800 positions – the group said on TuesdayExternal link.
The company said the job cuts will occur “across geographies” but would not specify which production sites or specific countries would be affected. The raft of redundancies is expected to cost the company between CHF25 million and CHF35 million ($26 million to $36 million), mostly in severance payments.
The group said it wants to reduce expenditure by at least CHF100 million this year compared to 2019.
Several plants had been forced to temporarily shutter their doors during the pandemic, including 13 in China in February and 25 in a variety of other locations, including Spain, Italy, India, Malaysia and Mexico.
The pandemic has also severely disrupted vital supply chain and logistics operations, the company said at its first quarter results presentation in Zurich.
The one positive note for OC Oerlikon during the pandemic was an increase in global demand for products used to manufacture face masks.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Switzerland condemned for deciding to deport gay Iranian
This content was published on
Switzerland violated the prohibition on inhuman treatment by considering that a gay Iranian could be returned to his country.
Gestational diabetes found to increase risk of adult-onset diabetes
This content was published on
A research team from the Lake Geneva region has identified persistent dysfunctions in glucose regulation in women with gestational diabetes. In the long term, this can increase the risk of adult-onset diabetes by up to ten times.
Swiss village must be evacuated by midday on Sunday
This content was published on
The village of Brienz-Brinzauls in eastern Switzerland, which is threatened by a rockfall, must be evacuated by 1pm on Sunday. All residents must leave the village.
This content was published on
A former judge of the Graubünden Administrative Court in eastern Switzerland has been found guilty of rape, sexual harassment and threatening a former trainee.
Costs and care time increase in Swiss retirement and nursing homes
This content was published on
In 2023 the costs of retirement and nursing homes increased by 5% compared to 2022 and those of assistance and care at home by 7%. Together, they amounted to CHF15 billion.
This content was published on
Almost half of the population in Switzerland shows clear to pronounced signs of smartphone addiction, according to a survey.
Swiss healthcare stakeholders want to save CHF300 million
This content was published on
The main players in the Swiss healthcare sector want to save around CHF300 million ($340 million) in healthcare costs a year from 2026.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What does business look like in a post-lockdown world?
This content was published on
Switzerland is easing up on the lockdown but what the new normal looks like for big companies is still a work in progress.
Switzerland facing biggest economic slump since 1975
This content was published on
In a revised forecast in the wake of the coronavirus pandemic, federal authorities predict GDP will contract by 6.7% in 2020.
This content was published on
The Zurich-based firm said on Tuesday that its textile division dragged overall sales down 40 per cent to SFr1.4 billion ($1.32 billion) from the previous year. Uwe Krüger, its chief executive officer since 2007, will leave the company immediately. Oerlikon’s board of directors has nominated Hans Ziegler, a fellow board member, to replace him. It…
Covid-19 is both threat and opportunity for Swiss biotech
This content was published on
Although the coronavirus pandemic is the Swiss biotech industry’s time to shine, it has left many smaller firms struggling to survive.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.